Featured Research

from universities, journals, and other organizations

Choice of seizure drug for brain tumor patients may affect survival

Date:
September 1, 2011
Source:
American Academy of Neurology
Summary:
New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures.

New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures. The research is published in the August 31, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.

"Despite some limitations, our results suggest that the choice of seizure medications in brain tumor patients should be carefully considered as it may give people a few more months with their loved ones," said study author Michael Weller, MD, with the University Hospital Zurich in Switzerland and a member of the American Academy of Neurology.

Seizures occur in up to half of all people with glioblastomas, the most common and most malignant brain tumor in adults. For those patients with seizures, treatment with one of several epilepsy drugs is highly recommended. After surgery, standard treatment for patients with newly diagnosed glioblastoma is radiation therapy together with the chemotherapy drug temozolomide.

For this study, researchers with the European Organization for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada Clinical Trials Group (NCIC) analyzed the use of epilepsy drugs by 573 brain tumor patients who had been enrolled in a clinical trial evaluating radiation therapy with and without temozolomide. When treatment started, 175 were not taking a seizure drug, while 398 patients were on anti-seizure medicine, including 97 patients who were taking valproic acid as their sole anti-seizure medication.

While the study showed that patients being treated with both chemotherapy and radiation fare better, those patients who also received valproic acid as medication for seizure prevention had an even further improved outcome, living an average of three months longer compared to those not receiving the drug.

While survival increased, people taking valproic acid in addition to radiation therapy and temozolomide were more likely than the other groups to experience a drop in blood platelets and white blood cells, which can increase a person's risk of bleeding and infection.

Taking valproic acid did not benefit survival in the group that received radiation therapy alone without temozolomide. Weller said that the use of valproic acid and other drugs with a similar mechanism should be further studied in order to determine whether and why valproic acid may help patients who are receiving radiation therapy and temozolomide live longer.

The study was supported by the National Cancer Institute in the United States and a grant from the Swiss Cancer League to the European Organization for Research and Treatment of Cancer Charitable Trust in Switzerland.


Story Source:

The above story is based on materials provided by American Academy of Neurology. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Weller, T. Gorlia, J. G. Cairncross, M. J. Van Den Bent, W. Mason, K. Belanger, A. A. Brandes, U. Bogdahn, D. R. Macdonald, P. Forsyth, A. O. Rossetti, D. Lacombe, R.-O. Mirimanoff, C. J. Vecht, R. Stupp. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology, 2011; DOI: 10.1212/WNL.0b013e31822f02e1

Cite This Page:

American Academy of Neurology. "Choice of seizure drug for brain tumor patients may affect survival." ScienceDaily. ScienceDaily, 1 September 2011. <www.sciencedaily.com/releases/2011/08/110831205926.htm>.
American Academy of Neurology. (2011, September 1). Choice of seizure drug for brain tumor patients may affect survival. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2011/08/110831205926.htm
American Academy of Neurology. "Choice of seizure drug for brain tumor patients may affect survival." ScienceDaily. www.sciencedaily.com/releases/2011/08/110831205926.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins